These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 24322303)

  • 1. Serum estrogen receptor bioactivity and breast cancer risk among postmenopausal women.
    Lim VW; Li J; Gong Y; Jin A; Yuan JM; Yong EL; Koh WP
    Endocr Relat Cancer; 2014 Apr; 21(2):263-73. PubMed ID: 24322303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of serum sex steroid receptor bioactivity and sex steroid hormones with breast cancer risk in postmenopausal women.
    Fourkala EO; Zaikin A; Burnell M; Gentry-Maharaj A; Ford J; Gunu R; Soromani C; Hasenbrink G; Jacobs I; Dawnay A; Widschwendter M; Lichtenberg-Fraté H; Menon U
    Endocr Relat Cancer; 2012 Apr; 19(2):137-47. PubMed ID: 22199143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum free estradiol and estrogen receptor-α mediated activity are related to decreased incident hip fractures in older women.
    Lim VW; Li J; Gong Y; Yuan JM; Wu TS; Hammond GL; Jin A; Koh WP; Yong EL
    Bone; 2012 Jun; 50(6):1311-6. PubMed ID: 22445734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioassays for estrogenic activity: development and validation of estrogen receptor (ERalpha/ERbeta) and breast cancer proliferation bioassays to measure serum estrogenic activity in clinical studies.
    Li J; Lee L; Gong Y; Shen P; Wong SP; Wise SD; Yong EL
    Assay Drug Dev Technol; 2009 Feb; 7(1):80-9. PubMed ID: 19382890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum estrogen receptor beta mediated bioactivity correlates with poor outcome in lung cancer patients.
    Lim VW; Lim WY; Zhang Z; Li J; Gong Y; Seow A; Yong EL
    Lung Cancer; 2014 Aug; 85(2):293-8. PubMed ID: 24951317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex hormone levels and risk of breast cancer with estrogen plus progestin.
    Farhat GN; Parimi N; Chlebowski RT; Manson JE; Anderson G; Huang AJ; Vittinghoff E; Lee JS; Lacroix AZ; Cauley JA; Jackson R; Grady D; Lane DS; Phillips L; Simon MS; Cummings SR
    J Natl Cancer Inst; 2013 Oct; 105(19):1496-503. PubMed ID: 24041978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective study of endogenous estrogens and breast cancer in postmenopausal women.
    Toniolo PG; Levitz M; Zeleniuch-Jacquotte A; Banerjee S; Koenig KL; Shore RE; Strax P; Pasternack BS
    J Natl Cancer Inst; 1995 Feb; 87(3):190-7. PubMed ID: 7707406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex hormone levels and risks of estrogen receptor-negative and estrogen receptor-positive breast cancers.
    Farhat GN; Cummings SR; Chlebowski RT; Parimi N; Cauley JA; Rohan TE; Huang AJ; Vitolins M; Hubbell FA; Manson JE; Cochrane BB; Lane DS; Lee JS
    J Natl Cancer Inst; 2011 Apr; 103(7):562-70. PubMed ID: 21330633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relation of serum levels of testosterone and dehydroepiandrosterone sulfate to risk of breast cancer in postmenopausal women.
    Zeleniuch-Jacquotte A; Bruning PF; Bonfrer JM; Koenig KL; Shore RE; Kim MY; Pasternack BS; Toniolo P
    Am J Epidemiol; 1997 Jun; 145(11):1030-8. PubMed ID: 9169912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum estrogen and SHBG levels and breast cancer incidence among users and never users of hormone replacement therapy.
    Würtz AM; Tjønneland A; Christensen J; Dragsted LO; Aarestrup J; Kyrø C; Overvad K; Olsen A
    Cancer Causes Control; 2012 Oct; 23(10):1711-20. PubMed ID: 22926300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women.
    Missmer SA; Eliassen AH; Barbieri RL; Hankinson SE
    J Natl Cancer Inst; 2004 Dec; 96(24):1856-65. PubMed ID: 15601642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum oestrogen receptor alpha and beta bioactivity are independently associated with breast cancer: a proof of principle study.
    Widschwendter M; Lichtenberg-Frate H; Hasenbrink G; Schwarzer S; Dawnay A; Lam A; Menon U; Apostolidou S; Raum E; Stegmaier C; Jacobs IJ; Brenner H
    Br J Cancer; 2009 Jul; 101(1):160-5. PubMed ID: 19491898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relation of serum levels of estrogen and dehydroepiandrosterone sulfate to hormone receptor status among postmenopausal women with breast cancer.
    Kakugawa Y; Minami Y; Tateno H; Inoue H; Fujiya T
    Breast Cancer; 2007; 14(3):269-76. PubMed ID: 17690503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum concentrations of estrogens, sex hormone-binding globulin, and androgens and risk of breast cancer in postmenopausal women.
    Adly L; Hill D; Sherman ME; Sturgeon SR; Fears T; Mies C; Ziegler RG; Hoover RN; Schairer C
    Int J Cancer; 2006 Nov; 119(10):2402-7. PubMed ID: 16894564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of serum estrone levels with estrogen receptor-positive breast cancer risk in postmenopausal Japanese women.
    Miyoshi Y; Tanji Y; Taguchi T; Tamaki Y; Noguchi S
    Clin Cancer Res; 2003 Jun; 9(6):2229-33. PubMed ID: 12796390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Prospective Evaluation of Endogenous Sex Hormone Levels and Colorectal Cancer Risk in Postmenopausal Women.
    Murphy N; Strickler HD; Stanczyk FZ; Xue X; Wassertheil-Smoller S; Rohan TE; Ho GY; Anderson GL; Potter JD; Gunter MJ
    J Natl Cancer Inst; 2015 Oct; 107(10):. PubMed ID: 26232761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex hormone measurements using mass spectrometry and sensitive extraction radioimmunoassay and risk of estrogen receptor negative and positive breast cancer: Case control study in UK Collaborative Cancer Trial of Ovarian Cancer Screening (UKCTOCS).
    Fourkala EO; Blyuss O; Field H; Gunu R; Ryan A; Barth J; Jacobs I; Zaikin A; Dawnay A; Menon U
    Steroids; 2016 Jun; 110():62-69. PubMed ID: 27091764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex hormone levels, breast cancer risk, and cancer receptor status in postmenopausal women: the ORDET cohort.
    Sieri S; Krogh V; Bolelli G; Abagnato CA; Grioni S; Pala V; Evangelista A; Allemani C; Micheli A; Tagliabue G; Schunemann HJ; Menard S; Berrino F; Muti P
    Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):169-76. PubMed ID: 19124495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma sex steroid hormones and breast cancer risk in Chinese women.
    Yu H; Shu XO; Shi R; Dai Q; Jin F; Gao YT; Li BD; Zheng W
    Int J Cancer; 2003 May; 105(1):92-7. PubMed ID: 12672036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women.
    Eliassen AH; Missmer SA; Tworoger SS; Spiegelman D; Barbieri RL; Dowsett M; Hankinson SE
    J Natl Cancer Inst; 2006 Oct; 98(19):1406-15. PubMed ID: 17018787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.